This is a call to oncologists for action

Micó, C; Berrocal, A; Blasco, A; Caballero, C; Iranzo, V; Lobo, M; Camps, C.
Clin. transl. oncol. (Print) ; 20(12): 1493-1501, dic. 2018. tab
Artigo Inglês | IBECS (Espanha) | ID: ibc-173756

Documentos relacionados

  1. Cancer costs and gender: a snapshot of issues, trends, and opportunities to reduce inequities using Australia as an example.
  2. Cutting-edge CAR-T cancer therapy is now made in India - at one-tenth the cost.
  3. Will the cost curve bend, even without reform?
  4. A Patient-Reported Outcome Instrument to Assess Symptom Burden and Predict Survival in Patients with Advanced Cancer: Flipping the Paradigm to Improve Timing of Palliative and End-of-Life Discussions and Reduce Unwanted Health Care Costs.
  5. Costs Cast Shadow on Optimism about Treatment.
  6. Proposal for the breakdown of increased cancer healthcare cost and its improvement.
  7. The Affordable Care Act and access to care across the cancer control continuum: A review at 10 years.
  8. [Forecast of costs of ecodependent cancer treatment for the development of management decisions].
  9. Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses.
  10. Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis.